Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Melioidosis is a life-threatening infectious disease caused by the gram-negative bacillus Burkholderia pseudomallei. An effective vaccine is needed, but data on protective immune responses in human melioidosis are lacking. We used ELISA and an antibody-dependent cellular phagocytosis assay to identify the major features of protective antibodies in patients with acute melioidosis in Thailand. We found that high levels of B. pseudomallei-specific IgG2 are associated with protection against death in a multivariable logistic regression analysis adjusting for age, diabetes, renal disease, and neutrophil count. Serum from melioidosis survivors enhanced bacteria uptake into human monocytes expressing FcγRIIa-H/R131, an intermediate-affinity IgG2-receptor, compared with serum from nonsurvivors. We did not find this enhancement when using monocytes carrying the low IgG2-affinity FcγRIIa-R131 allele. The findings indicate the importance of IgG2 in protection against death in human melioidosis, a crucial finding for antibody-based therapeutics and vaccine development.

Original publication

DOI

10.3201/eid2702.200213

Type

Journal article

Journal

Emerg Infect Dis

Publication Date

02/2021

Volume

27

Pages

463 - 470

Keywords

Burkholderia pseudomallei, FcγRIIA, H131, IgG subclasses, IgG2 subclass, R131, Thailand, antibodies, antimicrobial resistance, bacteria, bacterial infection, melioidosis, polymorphism, Adult, Antibodies, Bacterial, Burkholderia pseudomallei, Enzyme-Linked Immunosorbent Assay, Humans, Immunoglobulin G, Melioidosis, Thailand